An exploratory study to identify biomarkers of resistance to chemotherapy in multiple myeloma

An exploratory study to identify biomarkers of resistance to chemotherapy in multiple myeloma - biomarker study in MM

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000031866

Enrollment

Registered

2018-03-23

Start date

2018-03-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Filling out the written informed consent form before study participation of the patients' own volition Age 20 years or older

Exclusion criteria

Exclusion criteria: Patients who are found to be inappropriate for this trial as judged by the principal investigator or the sub-investigator

Design outcomes

Primary

Measure	Time frame
genetic mutations in tumor DNA	—

Secondary

Measure	Time frame
genetic mutations in circulating cell-free DNA	—

Countries

Japan

Contacts

Public ContactHiroshi Yasui

IMSUT hospital, The Institute of Medical Science, The University of Tokyo Department of Hematology/Oncology

hiroyasu@ims.u-tokyo.ac.jp03-5449-8111

Outcome results